Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.485 0.295 (7.04%) Market Cap: 716.43 Mil Enterprise Value: 1.21 Bil PE Ratio: 112.13 PB Ratio: 0 GF Score: 51/100

Ironwood Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2020 / 02:45PM GMT
Release Date Price: $9.64 (-8.19%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. Thank you for dialing in. Continuing on with our sessions for the day for our virtual health care conference, we have with us today management team from Ironwood. We have Tom McCourt, President; Gina Consylman, CFO; and Jeff Ruberti, Director, Corporate Strategy and Investor Relations. This is Balaji here, I cover spec pharma for Barclays, and this will be the last session from the spec pharma space.

Also, a reminder that owing to the nature of this format, there will be no Q&A sessions after the presentation. With that, I hand it over to Gina.

Gina R. Consylman
Ironwood Pharmaceuticals, Inc. - CFO, Senior VP & Treasurer

Thank you. Thank you to Barclays for hosting us. We very much appreciate the invitation. And thank you for your time and interest in Ironwood today. I am Gina Consylman, the CFO of Ironwood Pharmaceuticals. Tom McCourt, our President, is also here with me today. We're going to go through the presentation together and are looking forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot